Skip to main content

News 2023

Screening test predicts preterm preeclampsia during pregnancy

4 Oct 2023
Dr Ana Panigassi, Head of Clinical Affairs at Metabolomic Diagnostics, and Robin Tuytten, CEO of Metabolomic Diagnostics.
  • 15pc increase in detection of preterm preeclampsia by using a new diagnostic method.
  • UCC spin-out Metabolomic Diagnostics hope their new test can increase detection rates and save lives.
  • Difficult to predict, preeclampsia causes more than 70,000 maternal deaths and 500,000 foetal deaths every year.

Research and Innovation

Taighde agus Nuálaíocht

Office of Vice President for Research & Innovation 4th Floor Block E, Food Science Building UCC,

Top